CovidChloroV1, Main, Corpus, bibRecord, 000B10

Azithromycin in patients with COVID-19: Friend or foe?

Identifieur interne : 000B10 ( Main/Corpus ); précédent : 000B09; suivant : 000B11

Azithromycin in patients with COVID-19: Friend or foe?

Auteurs : Chia Siang Kow ; Syed Shahzad Hasan

Source :

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [ 1469-0691 ] ; 2021.

RBID : pubmed:33007473

English descriptors

KwdEn :
- Azithromycin (MeSH), COVID-19 (MeSH), Humans (MeSH), Hydroxychloroquine (MeSH), SARS-CoV-2 (MeSH).
MESH :
- chemical : Azithromycin, Hydroxychloroquine.
- COVID-19, Humans, SARS-CoV-2.

DOI: 10.1016/j.cmi.2020.09.047
PubMed: 33007473
PubMed Central: PMC7524443

Links to Exploration step

pubmed:33007473

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Azithromycin in patients with COVID-19: Friend or foe?</title>
<author><name sortKey="Kow, Chia Siang" sort="Kow, Chia Siang" uniqKey="Kow C" first="Chia Siang" last="Kow">Chia Siang Kow</name>
<affiliation><nlm:affiliation>School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia. Electronic address: chiasiang_93@hotmail.com.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hasan, Syed Shahzad" sort="Hasan, Syed Shahzad" uniqKey="Hasan S" first="Syed Shahzad" last="Hasan">Syed Shahzad Hasan</name>
<affiliation><nlm:affiliation>Department of Pharmacy, University of Huddersfield, Huddersfield, UK; School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, Australia.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2021">2021</date>
<idno type="RBID">pubmed:33007473</idno>
<idno type="pmid">33007473</idno>
<idno type="doi">10.1016/j.cmi.2020.09.047</idno>
<idno type="pmc">PMC7524443</idno>
<idno type="wicri:Area/Main/Corpus">000B10</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000B10</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Azithromycin in patients with COVID-19: Friend or foe?</title>
<author><name sortKey="Kow, Chia Siang" sort="Kow, Chia Siang" uniqKey="Kow C" first="Chia Siang" last="Kow">Chia Siang Kow</name>
<affiliation><nlm:affiliation>School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia. Electronic address: chiasiang_93@hotmail.com.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hasan, Syed Shahzad" sort="Hasan, Syed Shahzad" uniqKey="Hasan S" first="Syed Shahzad" last="Hasan">Syed Shahzad Hasan</name>
<affiliation><nlm:affiliation>Department of Pharmacy, University of Huddersfield, Huddersfield, UK; School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, Australia.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</title>
<idno type="eISSN">1469-0691</idno>
<imprint><date when="2021" type="published">2021</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Azithromycin (MeSH)</term>
<term>COVID-19 (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (MeSH)</term>
<term>SARS-CoV-2 (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Azithromycin</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>COVID-19</term>
<term>Humans</term>
<term>SARS-CoV-2</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">33007473</PMID>
<DateCompleted><Year>2020</Year>
<Month>12</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>12</Month>
<Day>29</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-0691</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>27</Volume>
<Issue>1</Issue>
<PubDate><Year>2021</Year>
<Month>01</Month>
</PubDate>
</JournalIssue>
<Title>Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</Title>
<ISOAbbreviation>Clin Microbiol Infect</ISOAbbreviation>
</Journal>
<ArticleTitle>Azithromycin in patients with COVID-19: Friend or foe?</ArticleTitle>
<Pagination><MedlinePgn>136-137</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S1198-743X(20)30601-7</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cmi.2020.09.047</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kow</LastName>
<ForeName>Chia Siang</ForeName>
<Initials>CS</Initials>
<AffiliationInfo><Affiliation>School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia. Electronic address: chiasiang_93@hotmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hasan</LastName>
<ForeName>Syed Shahzad</ForeName>
<Initials>SS</Initials>
<AffiliationInfo><Affiliation>Department of Pharmacy, University of Huddersfield, Huddersfield, UK; School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, Australia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
<PublicationType UI="D016420">Comment</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>09</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Clin Microbiol Infect</MedlineTA>
<NlmUniqueID>9516420</NlmUniqueID>
<ISSNLinking>1198-743X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>83905-01-5</RegistryNumber>
<NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Clin Microbiol Infect. 2021 Jan;27(1):19-27</RefSource>
<PMID Version="1">32860962</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D017963" MajorTopicYN="Y">Azithromycin</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>09</Month>
<Day>16</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>09</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>09</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>10</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>12</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>10</Month>
<Day>2</Day>
<Hour>20</Hour>
<Minute>10</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">33007473</ArticleId>
<ArticleId IdType="pii">S1198-743X(20)30601-7</ArticleId>
<ArticleId IdType="doi">10.1016/j.cmi.2020.09.047</ArticleId>
<ArticleId IdType="pmc">PMC7524443</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Am Health Drug Benefits. 2014 Sep;7(6):318-28</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25558301</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA Netw Open. 2020 Jun 1;3(6):e208199</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32585019</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Pharmacol Exp Ther. 2002 Oct;303(1):218-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12235254</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Microbiol Infect. 2021 Jan;27(1):19-27</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32860962</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Circ Arrhythm Electrophysiol. 2017 Apr;10(4):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28408648</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B10 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000B10 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:33007473
   |texte=   Azithromycin in patients with COVID-19: Friend or foe?
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:33007473" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Azithromycin in patients with COVID-19: Friend or foe?

Azithromycin in patients with COVID-19: Friend or foe?

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki